In the Phase III DeLLphi-304 trial, patients with small cell lung cancer administered Imdelltra achieved a statistically ...

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that on April 14, 2025, ...

Amgen has shared positive results from a late-stage study of its immunotherapy Imdelltra (tarlatamab-dlle) in small cell lung cancer (SCLC). The global DeLLphi-304 trial has been comparing the drug ...

Amgen's global Phase III DeLLphi-304 trial of Imdelltra has met its primary endpoint at a planned interim analysis for ...

First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy, for Patients With Progression On or After Platinum-Based Chemotherapy ...

Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.

King family opposes release of classified documents on King's assassination, citing privacy concerns and potential harm to ...

Nearly a year after winning an accelerated approval for its DLL3-targeting small cell lung cancer (SCLC) therapy Imdelltra, ...

The study is investigating the drug as a treatment for patients with small cell lung cancer (SCLC) who progressed on or after ...

DNI Tulsi Gabbard said Thursday that the assassination files of Martin Luther King Jr. and Robert F. Kennedy would be released in "the next few days." ...

WASHINGTON, D.C. - The Lawyer’s Committee for Civil Rights Under Law has filed a brief here April on behalf of the Southern ...

David Spigel, MD, discusses the significant benefits of durvalumab as consolidation therapy following standard ...